🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Cancer-related fatigue—mechanisms, risk factors, and treatments

Julienne E. Bower (2014)

Nature Reviews Clinical Oncology

1.5K citesjournal articlePDF

The Role of Non-coding RNAs in Oncology

Frank J. Slack, Arul M. Chinnaiyan (2019)

Cell

1.5K citesjournal articlePDF

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Antoni Ribas, Igor Puzanov et al. (2015)

The Lancet Oncology

1.4K citesjournal articlePDF

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

Sherene Loi, Nicolas Sirtaine et al. (2013)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

International incidence of childhood cancer, 2001–10: a population-based registry study

Eva Steliarova-Foucher, Murielle Colombet et al. (2017)

The Lancet Oncology

1.5K citesjournal articlePDF

Immune evasion in cancer: Mechanistic basis and therapeutic strategies

Dass S. Vinay, Elizabeth P. Ryan et al. (2015)

Seminars in Cancer Biology

1.4K citesjournal articlePDF

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Giuseppe Giaccone, Roy S. Herbst et al. (2004)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

Leonard B. Saltz, Neal J. Meropol et al. (2004)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Martin Reck, Delvys Rodríguez–Abreu et al. (2019)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Roy S. Herbst, Giuseppe Giaccone et al. (2004)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

Edward Shaw, Charles Scott et al. (2000)

International Journal of Radiation Oncology*Biology*Physics

1.4K citesjournal articlePDF

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, M. Dror Michaelson et al. (2006)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

Quinn T Ostrom, Haley Gittleman et al. (2017)

Neuro-Oncology

1.4K citesjournal articlePDF

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian et al. (2006)

Journal of Clinical Oncology

1.4K citesjournal articlePDF

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

M J Brady, D F Cella et al. (1997)

Journal of Clinical Oncology

1.4K citesjournal articlePDF